{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:39:42Z","timestamp":1707525582314},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,2]]},"DOI":"10.7759\/cureus.51499","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T09:27:35Z","timestamp":1704187655000},"source":"Crossref","is-referenced-by-count":0,"title":["The Trend of C-Reactive Protein After Corticosteroid Therapy in COVID-19 Patients Admitted to IGIMS, Patna"],"prefix":"10.7759","author":[{"given":"Neelima","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randhir","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweta","family":"Muni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namrata","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu N","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020, 382:727-33. 10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"ref2","unstructured":"IndiaFightsCorona COVID-19. (2020). Accessed. May 6, 2023: https:\/\/www.mygov.in\/covid-19."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from Northern Italy: a two-centre descriptive study","volume":"20","author":"Carsana L","year":"2020","unstructured":"Carsana L, Sonzogni A, Nasr A, et al.. Pulmonary post-mortem findings in a series of COVID-19 cases from Northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020, 20:1135-40. 10.1016\/S1473-3099(20)30434-5","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore JB","year":"2020","unstructured":"Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020, 368:473-4. 10.1126\/science.abb8925","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby P","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, et al.. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021, 384:693-704. 10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.25384","article-title":"Funding of pharmaceutical innovation during and after the COVID-19 pandemic","volume":"325","author":"Robinson JC","year":"2021","unstructured":"Robinson JC. Funding of pharmaceutical innovation during and after the COVID-19 pandemic. JAMA. 2021, 325:825-6. 10.1001\/jama.2020.25384","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland GA","year":"2020","unstructured":"Poland GA, Ovsyannikova IG, Kennedy RB. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet. 2020, 396:1595-606. 10.1016\/S0140-6736(20)32137-1","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2020.1830760","article-title":"Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome","volume":"20","author":"Azar MM","year":"2020","unstructured":"Azar MM, Shin JJ, Kang I, Landry M. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome. Expert Rev Mol Diagn. 2020, 20:1087-97. 10.1080\/14737159.2020.1830760","journal-title":"Expert Rev Mol Diagn"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay MZ","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LF. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020, 20:363-74. 10.1038\/s41577-020-0311-8","journal-title":"Nat Rev Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.720363","article-title":"Update advances on C-reactive protein in COVID-19 and other viral infections","volume":"12","author":"Luan YY","year":"2021","unstructured":"Luan YY, Yin CH, Yao YM. Update advances on C-reactive protein in COVID-19 and other viral infections. Front Immunol. 2021, 12:720363. 10.3389\/fimmu.2021.720363","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.07.007","article-title":"Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages","volume":"122","author":"Goleva E","year":"2008","unstructured":"Goleva E, Hauk PJ, Hall CF, Liu AH, Riches DW, Martin RJ, Leung DY. Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J Allergy Clin Immunol. 2008, 122:550-9. 10.1016\/j.jaci.2008.07.007","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis EJ","year":"2020","unstructured":"Giamarellos-Bourboulis EJ, Netea MG, Rovina N, et al.. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020, 27:992-1000.e3. 10.1016\/j.chom.2020.04.009","journal-title":"Cell Host Microbe"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.4.1192","article-title":"C-reactive protein in pneumonia: let me try again","volume":"125","author":"Luna CM","year":"2004","unstructured":"Luna CM. C-reactive protein in pneumonia: let me try again. Chest. 2004, 125:1192-5. 10.1378\/chest.125.4.1192","journal-title":"Chest"},{"key":"ref15","article-title":"Harrison\u2019s Principle of Internal Medicine","unstructured":"Harrison\u2019s Principle of Internal Medicine. Infectious diseases, vol. 944 (ed):"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston NR","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018, 9:754. 10.3389\/fimmu.2018.00754","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(01)00042-6","article-title":"Human C-reactive protein: expression, structure, and function","volume":"38","author":"Volanakis JE","year":"2001","unstructured":"Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol. 2001, 38:189-197. 10.1016\/S0161-5890(01)00042-6","journal-title":"Mol Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-018-1188-x","article-title":"C-reactive protein as a biomarker of\u00a0severe H1N1 influenza","volume":"68","author":"Vasileva D","year":"2019","unstructured":"Vasileva D, Badawi A. C-reactive protein as a biomarker of\u00a0severe H1N1 influenza. Inflamm Res. 2019, 68:39-46. 10.1007\/s00011-018-1188-x","journal-title":"Inflamm Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa641","article-title":"Prognostic value of C-reactive protein in patients with COVID-19","volume":"71","author":"Luo X","year":"2020","unstructured":"Luo X, Zhou W, Yan X, et al.. Prognostic value of C-reactive protein in patients with COVID-19. Clin Infect Dis. 2020, 71:2174-9. 10.1093\/cid\/ciaa641","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25770","article-title":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19","volume":"92","author":"Gao Y","year":"2020","unstructured":"Gao Y, Li T, Han M, et al.. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020, 92:791-6. 10.1002\/jmv.25770","journal-title":"J Med Virol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.2033","article-title":"Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19","volume":"180","author":"Liang W","year":"2020","unstructured":"Liang W, Liang H, Ou L, et al.. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020, 180:1081-9. 10.1001\/jamainternmed.2020.2033","journal-title":"JAMA Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi HK","year":"2020","unstructured":"Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020, 39:405-7. 10.1016\/j.healun.2020.03.012","journal-title":"J Heart Lung Transplant"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3497","article-title":"Effect of systemic glucocorticoids on mortality or mechanical ventilation in patients with COVID-19","volume":"15","author":"Keller MJ","year":"2020","unstructured":"Keller MJ, Kitsis EA, Arora S, et al.. Effect of systemic glucocorticoids on mortality or mechanical ventilation in patients with COVID-19. J Hosp Med. 2020, 15:489-93. 10.12788\/jhm.3497","journal-title":"J Hosp Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0158-2","article-title":"A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia","volume":"5","author":"Wang Y","year":"2020","unstructured":"Wang Y, Jiang W, He Q, et al.. A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia. Signal Transduct Target Ther. 2020, 5:57-10. 10.1038\/s41392-020-0158-2","journal-title":"Signal Transduct Target Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa601","article-title":"Early short course corticosteroids in hospitalized patients with COVID-19","volume":"71","author":"Fadel R","year":"2020","unstructured":"Fadel R, Morrison AR, Vahia A, et al.. Early short course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis. 2020, 71:2114-20. 10.1093\/cid\/ciaa601","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: a cohort study","volume":"2","author":"Huet T","year":"2020","unstructured":"Huet T, Beaussier H, Voisin O, et al.. Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol. 2020, 2:e393-400. 10.1016\/S2665-9913(20)30164-8","journal-title":"Lancet Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014963","article-title":"Systemic corticosteroids for the treatment of COVID-19","volume":"8","author":"Wagner C","year":"2021","unstructured":"Wagner C, Griesel M, Mikolajewska A, et al.. Systemic corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev. 2021, 8:CD014963. 10.1002\/14651858.CD014963","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/213529-the-trend-of-c-reactive-protein-after-corticosteroid-therapy-in-covid-19-patients-admitted-to-igims-patna","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:37Z","timestamp":1707509617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/213529-the-trend-of-c-reactive-protein-after-corticosteroid-therapy-in-covid-19-patients-admitted-to-igims-patna"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.51499","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,2]]}}}